Drug intelligence / Profile preview

Bebulin

Development stage
Unknown
Lead developer
Baxter Healthcare Corporation
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Bebulin is a 3-factor prothrombin complex concentrate (PCC) derived from human plasma, containing concentrated levels of coagulation factors II, IX, and X, with low levels of factor VII. It is primarily indicated for the prevention and control of bleeding episodes in patients with Hemophilia B (Factor IX deficiency). In the clinical research context at The University of Texas Health Science Center at Houston, Bebulin is utilized as part of a damage control resuscitation strategy to manage dilutional coagulopathy and thrombocytopenia in neonates and infants undergoing open-heart surgery with cardiopulmonary bypass. By providing exogenous clotting factors, it helps restore the hemostatic balance that is often disrupted by hemodilution and the consumption of factors during surgery.

Brand names
BebulinBebulin VH
Other names
factor ix complex concentrate3-factor prothrombin complex concentrate3-factor PCCFactor IX ComplexFactor IX Complex (Human)
02

Targets

F7 (Coagulation Factor VII)F2 (Thrombin)F9 (Coagulation Factor IX)F10 (Factor Xa)

Beyond the preview

Go deeper on Bebulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bebulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call